December 2015

In 2016, more than 27,000 adults in the US will be diagnosed with multiple myeloma (MM). Although MM remains an incurable disease, the encouraging news is that between 2000 and 2009 there was a 73% increase in survivors. However, despite recent advances, MM continues to be a challenge for health care professionals to control. Because MM displays considerable heterogeneity, loss of control of the disease in the form of relapse is becoming more commonplace. To counteract this, newer management approaches such as collaborative practice, risk strategy, and individualized therapy are essential. 

Thus, JADPRO—Journal of the Advanced Practitioner in Oncology presents Multiple Myeloma Updates, a monthly educational newsletter. Editorial content will be provided by practicing physicians, physician assistants, nurse practitioners, and pharmacists with expertise in the diagnosis and management of MM. I hope you find this to be a useful resource in your practice!

Beth Faiman, PhD, APN-BC, AOCN

Nurse Practitioner
Multiple Myeloma Program
Taussig Cancer Institute
Cleveland Clinic
Cleveland, Ohio


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.